Mirabegron in patients with pulmonary hypertension: the SPHERE-HF trial.

28 August 2022 (17:00 - 17:15)
Organised by:
Congress Presentation Part of: Beta3 adrenergic agonists in the clinic: the end of the beginning Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo

Hospital Clinic, University of Barcelona, Barcelona (Spain)

The Event

Event poster

ESC Congress 2022

28 August 2022 17:00 CET
You may be interested in